Introduction
Recurrent bacterial pneumonia has recently been included among the clinical criteria for acquired immunodeficiency syndrome (AIDS), since bacterial pneumonia rates are significantly higher in patients with AIDS and they are often associated with the advanced stage of immunodepression (1) . Although Staphylococcus aweus has been recognized as the most frequency cause of bacteraemia in HIV-infected patients (2-4), it has not been indicated previously as a frequent cause of pneumonia (5-8). However, the real incidence of S. aureus pneumonia (SAP) in HIV-infected patients still remains undefined. In fact, many individuals may develop SAP before their HIV status is known and, in addition, patients with known HIV infection and respiratory syndrome often take trimethoprimsulphamethoxazole (as a prophylaxis or therapeutically) for presumed or proven Pneumocystis carinii pneumonia (PCP), which makes aetiologic diagnosis of bacterial pneumonia difficult (6,8). The results of prospective cohort studies are not yet available, but it is possible to speculate that trimethoprimsulphamethoxazole therapy for presumed or proven PCP can reduce the rate of SAP in AIDS patients. At present, there is only one report (9) of SAP in HIV-infected patients which demonstrates that this infection often occurs in patients with other pulmonary diseases (PCP and Kaposi's sarcoma), and that it is associated with a significant mortality. In this study (9), however, the risk factors for SAP have not been detailed, and the analysis of the parameters influencing the mortality have not been included. The objectives of the present study were to better characterize the frequency, the risk factors and the clinical features of SAP associated with HIV infection, and the effect of these parameters on the disease outcome. therapy and usage of a central venous catheter (CVC). A patient was considered as a smoker if he/she smoked more than 10 packsyear -i. Neutropenia was defined as an absolute neutrophil count less than 1000 mmp3.
The diagnosis of bacterial pneumonia was considered if a bacteria (other than Mycobacteria) was isolated from a specimen of sputum representative of the lower airways (i.e. 2 25 polymorphonuclear cells and _< 10 epithelial cells per 100 x microscopic field) and/or from bronchoalveolar lavage (BAL) and/or from blood, in patients with parenchymal infiltrates on chest X-ray and respiratory symptoms, i.e. cough with/without expectoration and/or chest pain. If another possible cause of pneumonia was present at the same time as SAP, the patient in question was not included in the study. Community-acquired pneumonia was defined as an infection which occurred in a patient who had not been hospitalized within the I days preceding the onset of pulmonary symptoms. Nosocomial pneumonia was defined as an infection which occurred at least 72 h after hospital admission or occurred in a patient who had been hospitalized in the previous 2 weeks. A recurrence of pneumonia was considered if a new episode of SAP occurred after recovery from the first episode.
The attack rate for S. aureus pulmonary infection was calculated as the number of episodes of SAP associated with HIV infection, divided by the total number of HIV-related hospital admissions x 1000. For the case-control study, each case was paired with two unmatched controls, selected at random from the same ward as the cases during the study period. These controls were HIV-infected patients without pneumonia and without sign of staphylococcal infection.
The variables determined to be either present or absent in each case were also recorded for each control. The day of selection of the control was the cut-off date for determining the presence or absence of the variables.
STATISTICAL ANALYSIS Quantitative variables were tested for normal distribution and compared using Student's two-tailed t-test. Differences in group proportions were assessed using X2-test or, for small numbers, using Fisher's exact test. Potential risk and prognostic factors for pneumonia were analysed by univariate methods to screen (if a factor was significant) for inclusion in a multivariate model. For the analysis of the indicators of prognosis, the variable with the lowest death rate was given a relative odds ratio (OR) of 1 and this was later used as a reference category. Multivariate analysis was performed with a logistic regression model, and 95% test-based confidence intervals (CI) were used to determine the statistical significance of the OR. A stepward approach was used with 0.05 as a limit for entering new terms. All variables were entered in the logistic regression as categoric variables with two categories (O=absent or normal; 1 =present or abnormal).
For those variables with more than two categories, a cut-off point was selected according to the results of the univariate analysis. Two-tailed tests of significance at the PcO.05 level were used to determine statistical significance.
Results
In the study period, 154 episodes of bacterial pneumonia were observed in 136 patients. Staphylococcus aureus pneumonia was diagnosed in 24 episodes of pneumonia (16%) which occurred in 19 patients. Staphylococcus aweus was also isolated in association with Streptococcus pneumoniae (three patients), Pseudomonas aeruginosa (two patients) and Enterobacter faecium (one patient). These patients were, however, excluded from the study. The attack rate for SAP was 8.31 per 1000 patients in the 2887 HIV-related hospital admissions observed in the study period. The rate of SAP in the total yearly HIV-related admission increased progressively and is now 1.2% without substantial fluctuations from 1990. Patients were followed for an average of 16 months (range l-42, median 11 months). Thirteen patients (68%) were male and six patients were female (32%); their ages ranged from 18 to 67 years (mean age: 35 * 9 years). Risk factors for HIV were: IVDA (84%), homosexual (10%) and heterosexual (6%)
contacts. According to the 1992 CDC AIDS definition (1) five patients were in the B3 (26%) and 14 patients were in the C3 (74%) category. The recurrence of SAP was an AIDS-defining condition in one patient alone. The patients in the C3 category were diagnosed with AIDS O&48 months (median 27 f 5 months) prior to the onset of SAP. The mean T CD4+ cell count was 40 mm-3 (range 1-167 mm -') and the mean PMN cell number was 2550 Vmrn3
(range 47339400 Vme3). The infection was community acquired in 13 cases (68%) and nosocomial in six cases (32%). For the characteristics of the patients, see Table 1 .
RISK FACTORS
Univariate analysis identified three risk factors significantly associated with SAP: (1) IVDA (P=O.O2 vs. control group, OR=4.80);
(2) history of previous PCP (P=O.O3, OR=4.95);
and (3) cirrhosis (P=O.O3, OR=6.60) (see Table 2 ). On the contrary, no statistically significant relationship was found between SAP and the following parameters: age, sex, HIV risk behaviour (other than IVDA), AIDS-related conditions, time from AIDS diagnosis, nutritional status, cigarette smoking, alcoholism, diabetes, previous episode of pneumonia (with the exception of PCP), presence of chronic pulmonary diseases, chronic renal failure, neoplastic diseases, use of corticosteroids, CVC, neutropenia and low T CD4+ cells (~50 mm-').
The results of the Poisson model revealed that IVDA (P=O.O2) and previous PCP (P=O.O3) were the sole independent risk factors for the development of SAP. No other variables or interactions were statistically significant.
MICROBIOLOGICAL DATA
Staphylococcus aureus was isolated from sputum in 15 patients (79%) (two or more samples) and from BAL in seven patients (37%). In 10 patients (53%) blood cultures were positive for S. aureus. In one patient, trans-thoracic needle aspiration of a lung abscess yielded pure growth of S. aureus, and in one additional patient, S. aureus was isolated from pleural fluid.
The analysis of the antibiotic in vitro susceptibility of the S. aureus isolates showed that the rate of penicillin-methicillin-resistant strains was 14%. No resistance to glycopeptides (vancomycin or teicoplanin) was documented in any of the isolates. CLINICAL 
AND RADIOLOGICAL FINDINGS
All patients presented with fever (range 37.6-4O.l"C) and had an acute or sub-acute presentation of the illness. The most common symptoms were productive cough (74%) shortness of breath (37%) and pleuritic chest pain (26%) (see Table 1 ). On physical examination, abnormal breath sounds were observed in all cases. The mean respiratory rate was 22 & 7 breaths min -'. The mean PaO, was 71 & 12 mmHg. In particular, six patients (31%) were hypoxaemic with PaO, ~60 mmHg.
The radiological findings of SAP included lobar consolidation (78%), predominantly in the lower lobes (67%), consolidation with cavitation (11%) and interstitial nodular infiltrates (llO%) (see Table 1 ). In two patients (11%) SAP was bilateral. Pleural effusion was present in six patients (31%), and empyema was present in one of these patients. One patient, with cavitation and pleural effusion, developed pneumothorax and died after 72 h. There was no significant relationship between the presence of effusion and the number of affected lobes, or whether there was bilateral vs. monolateral involvement. None of the patients with positive blood cultures had echocardiographic evidence of right-sided endocarditis, and six active intravenous drug abusers, in whom pulmonary scintigraphy was performed, had no evidence of pulmonary embolisms. OUTCOME All patients were treated with antibiotic therapy which consisted of intravenous penicillinase-resistant p lactams or glycopeptides given for a mean of 14.3 days. The response to therapy was favourable in 84% of the patients. Three patients (16%) died with SAP as a direct or contributing cause of the death. In five patients (26%), SAP recurred within 2-6 months. Using the univariate analysis, the following factors were significantly associated with higher mortality:
(1) recurrence (P=O,Ol, OR= 18) and (2) low TCD4+ cells level (~50mrn-~) (P=O.O3, OR= 14.6). However, sex, age, chronic lung diseases, AIDS-related conditions, clinical and radiological findings, and neutropenia were not significantly associated with a higher fatality rate. The multivariate analysis indicated that the low T CD4+ cell number (C 50 mm -3, was the only independent risk factor for mortality (P= 0.02, OR= 13.4).
Discussion
Staphylococcus aureus is responsible for serious pulmonary infections in immunocompetent subjects (range l-10% for community-acquired; about 10% for nosocomial pneumonia) (10,ll). The first and largest study on SAP in adults was published by Chickering and Park in 1919, in the wake of the 1918 defined that SAP tends to occur in older patients with concomitant diseases (except during an influenza epidemic, when a higher percentage of young subjects can be infected), in post-operative status, in intensive care units or in mid-length hospitalization (13,14). Intravenous drug addiction is also considered to be a SAP risk factor (15).
In HIV-infected patients, S. aureus has been reported as the most common cause of bacteraemia (2-4) and, less frequently, as a cause of pulmonary infections (5-8). Although a deficit in T CD4+ cells is the most relevant immunological alteration in AIDS patients, quantitative or qualitative deficits of polymorphonuclear cells have also been documented in these patients (16,17), and they seem to be relevant for the development of S. aureus infections (18). In particular, it has been reported that neutrophils from homosexuals with AIDS have a defect (not related to abnormal chemotaxis) in their ability to the in vitro killing of 5'. aureus compared to normal subjects, and this may contribute to the development of S. aureus infections (19).
In the present study, SAP occurred in a frequency exceeding that observed in the general population (lo), with a significative increase in the last few years.
In two-thirds of patients, S. aureus pulmonary infection was community acquired, contrary to reports of immunocompetent patients in whom nosocomial origin of SAP is more common (11). However, both these results can be related to the high number of intravenous drug abusers in these patients.
Even though the predisposing factors of SAP in immunocompetent hosts are well defined (13,14), at present no statistical studies have detailed the predictors of SAP in HIV-infected patients. In the present series of patients, IVDA, previous PCP and cirrhosis were significant risk factors for the development of SAP. In particular, intravenous drug abusers represent the more relevant HIV-risk group with staphylococcal pneumonia. The specific risk for this infection is the result of endogenous and exogenous factors: malnutrition, poor personal hygiene and the recurrent exposure to bacterial agents, including S. aureus. In fact, this micro-organism can not only contaminate the skin but it is also present in greater numbers in the nose and throat of intravenous drug abusers than in the general population (20). Interestingly, the cultures of street heroin and injection needles have not revealed the presence of S. aureus (21). However, the real impact of intravenous drug abuse on the development of SAP is difficult to be quantified since the large majority of the present patients, and of the Italian HIV-infected patients in general, are intravenous drug abusers (22).
Previous observations (9,23) have indicated that other lung diseases, in particular Kaposi's sarcoma and PCP, are highly associated with SAP. In the present patients, pulmonary
Kaposi's sarcoma was not a significant risk condition, while previous episodes of PCP significantly increased the risk for the development of SAP. This is probably related to the superinfection by S. aureus of the cysts or pneumatoceles that are frequently present in the lung after recovery from PCP (24). Alternatively, it is also possible that P. car&ii may damage the bronchial mucosal integrity, predisposing the patients to S. aureus infection. In addition, patients with previous episodes of PCP usually have a low number of T CD4+ cells and also present with alterations of other defence mechanisms, which favours the development of bacterial pneumonia (24). Patients with cirrhosis, in particular alcoholic cirrhosis, are more likely to develop bacterial pneumonia as a result of the decreased resistance to infections (25), often consequent to deficits of neutrophil function, impaired complement response, defective mobility to opsonize bacteria and impaired reticula-endothelial function (26). Moreover, chronic hepatitis and cirrhosis are frequently observed in IVDA patients; the group of HIV patients most commonly presenting with SAP.
Although the concomitant effect of these risk factors can be responsible for the high number of SAP observed in HIV-infected patients, multivariate analysis indicated that IVDA and previous PCP were the sole independent risk factors associated with the development of SAP.
The clinical and radiological characteristics of S. aureuz pulmonary infection in the present series of patients are similar to those reported previously in non-AIDS patients (IO), with the exception of the blood cultures which were positive in about half of the patients. This percentage, higher than that reported in HIV-seronegative patients (13,14), indirectly supports the possible haematogenous spread of S. aureus infection in many of the present patients, a significant number of whom were intravenous drug abusers. Against this possibility, however, is the observation that in patients with SAP and positive blood cultures, the clinical presentation, radiological (including pulmonary scintigraphy) and echocardiographic findings were more likely to be indicative of a primary, rather than a secondary to haematogenous spread, pneumonia and that none of these patients had evidence of right-sided endocarditis signs or pulmonary embolisms.
Since the recovery of S. aureus from sputum has a low specificity, it was only considered to be indicative of an aetiologic role for pneumonia if two or more positive samples were obtained without the presence of other possible aetiologic agents. Moreover, since the response rate to anti-staphylococcal therapy observed in these patients was the same regardless of the source of isolation (blood, BAL or sputum), this result indirectly confirms the correct application of this diagnostic criteria.
Chest X-ray generally showed typical lobar involvement (predominantly in lower lobes), which was frequently associated with pleural effusion and, in one patient only, with pulmonary abscess. This last finding, in contrast to what is often observed in immunocompetent subjects (27), can be related to the quantitative and qualitative deficits of neutrophils which are observed frequently in AIDS patients (16,17). It is noteworthy that in a few patients in whom interstitial nodular infiltrates were observed, the BAL was used to discriminate from other aetiologic causes of pulmonary infections and, in particular, P. carinii and Mycobacteria.
In the authors' experience, the outcome of SAP treated with specific anti-staphylococcal therapy was favourable in the majority of patients. This contrasts with the high mortality (30-50%) of S. aureus pulmonary infection reported in HIV-seronegative patients that developed pneumonia a few days after the onset of influenza (12). The authors suggest, on a purely speculative ground, that the relatively low number of penicillin-resistant S. aureus isolates associated with an early diagnosis and treatment of patients (otherwise in follow-up for HIV infection) influenced the prognosis positively. The percentage of recurrence, difficult to compare with other studies since 5'. aureus pneumonia is not always clearly sorted from other types of pneumonia, is probably the consequence of the severe immunodeficiency even though it is difficult to exclude the role of an early interruption of the therapy for the low compliance of some patients, especially in drug abusers.
The univariate analysis revealed that the low level of circulating T CD4+ cells (~50 mm -3, and the occurrence of relapse influenced the prognosis negatively, but only the low number of T CD4+ cells was, on multivariate analysis, an independent prognostic factor. This indicates that the profound immunodeficiency observed in patients with advanced AIDS is the most important factor influencing the survival of patients with SAP.
In conclusion, this study emphasizes the emerging importance of S. aureus as aetiologic agent of pulmonary infections in patients with AIDS. Although other micro-organisms, such as S. pneumoniae and Haemophilus inzuenzae, which are frequent causes of bacterial pneumonia in HIV-infected patients (7), may present the same clinical picture, an acute presentation with lobar involvement and pleural effusion on chest X-ray should be evaluated carefully for the possibility of SAP in HIV-infected patients, especially in intravenous drug abusers and those with previous PCP.
